Clinical trials: Acquired Immunodeficiency Syndrome
Influenza With Pneumonia, Influenza Virus Identified
Influenza Vaccine in HIV Infected Children
Influenza associated pneumonia causes significant morbidity in young HIV-infected children. Although annual vaccination against influenza is recommended for HIV infected children, it has not been implemented as routine care, due…
- Trial name
- NCT00883012
- Testing
- Trivalent sub-unit influenza vaccine, Saline, 0.5ml
- Where
- South Africa
- Volunteers
- 412 people
- Sponsor
- University of Witwatersrand, South Africa
Human Immunodeficiency Virus-1
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients
This is a pilot study to examine if the novel treatment regimen maraviroc plus boosted atazanavir can be expected to be safe and efficacious in treatment naive HIV infected patients.
- Trial name
- NCT00827112
- Testing
- maraviroc
- Where
- 39 sites in United States, Germany and 1 more
- Volunteers
- 129 people
- Sponsor
- ViiV Healthcare
Hiv, HIV-1-infection
Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test
The purpose of this study is to evaluate the efficacy of DTG + 3TC versus DTG + TDF/FTC over 48 weeks in HIV-1 naive patients in a real life setting with no baseline HIV genotypic resistance testing available.
- Trial name
- D2ARLING (NCT04549467)
- Testing
- Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill
- Where
- Argentina
- Volunteers
- 244 people
- Sponsor
- Fundacion IDEAA
HIV Infections, HIV
Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention
This project called Mobile Technology and Incentives (MOTIVES) aims to increase engagement with HIV prevention information and improve testing frequency among Latino/a men who have sex with men (MSM) and transgender women (TGW).
- Trial name
- MOTIVES (NCT03144336)
- Testing
- Information provision, Weekly quizzes, Rewards for testing HIV-negative
- Where
- United States
- Volunteers
- 217 people
- Sponsor
- RAND
Human Immunodeficiency Virus, Human Immunodeficiency Virus I Infection
HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
The goal of this randomized clinical trial is to evaluate the safety and immunogenicity of the HIV Therapeutic DNA Vaccine (ICVAX) in participants with HIV-1 infection under antiretroviral therapy (ART).
- Trial name
- NCT07530198
- Testing
- ICVAX (TERESA-EPT I device), ICVAX (PharmaJet Tropis device), ICVAX (TriGrid device)
- Where
- Hong Kong
- Volunteers
- 22 people
- Sponsor
- Immuno Cure Holding (HK) Limited
HIV
Niacin on Immune Activation : a Proof-of-concept Study
There are a number of powerful anti-HIV drugs, which keep the virus at undetectable levels and enable HIV-infected individuals to live longer.
- Trial name
- NCT02018965
- Testing
- Niacin
- Where
- Canada
- Volunteers
- 16 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
HIV
Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission
The purpose of this study is to modify the HITSystem to engage and retain HIV+ pregnant women before, during and after delivery and evaluate the HITSystem impact on prevention of mother-to-child transmission (PMTCT) related…
- Trial name
- NCT02726607
- Testing
- HIV Infant Tracking System (HITSystem) 2.0, Standard of PMTCT care
- Where
- 3 sites in United States, Kenya
- Volunteers
- 157 people
- Sponsor
- University of Kansas Medical Center
Opiate Dependence, HIV Infections
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
A randomized clinical trial evaluating the reduction of HIV risk behaviors and drug use when providing integrated behavioral drug and HIV risk reduction counseling (BDRC) along with methadone maintenance treatment in Wuhan, China
- Trial name
- NCT00757744
- Testing
- Behavioral Drug and HIV Risk Reduction Counseling (BDRC), Drug counseling
- Where
- 2 sites in United States, China
- Volunteers
- 45 people
- Sponsor
- Yale University
Infection, Human Immunodeficiency Virus
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
The purpose of this study is to assess the safety, efficacy, tolerability and pharmacokinetics of four doses of BMS-663068 with Raltegravir (RAL) + Tenofovir Disoproxil Fumarate (TDF).
- Trial name
- NCT01384734
- Testing
- BMS-663068 400 mg, BMS-663068 800 mg, BMS-663068 600 mg
- Where
- 54 sites in United States, Argentina and 8 more
- Volunteers
- 254 people
- Sponsor
- ViiV Healthcare
HIV Infections
Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants
To evaluate the single dose pharmacokinetic profile of Viracept pediatric powder formulation administered to HIV infected or exposed children and infants (0 to 13 years of age).
- Trial name
- NCT00002164
- Testing
- Nelfinavir mesylate
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- Agouron Pharmaceuticals
Human Immunodeficiency Virus, Depression
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention
Project AProaCH is an open pilot trial of a cognitive behavioral therapy (CBT) for individuals with HIV with various psychological comorbidities, which the investigators call "syndemics".
- Conditions
- Human Immunodeficiency Virus, Depression, Mental Health
- Trial name
- APPROACH (NCT02696681)
- Testing
- Cognitive Behavioral Therapy
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- University of Miami
HIV Infections
The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
The purpose of this study is to see if offering a general health screening tailored towards high-risk groups (African immigrants, injection drug users (IDUs), and minority men who have sex with men (MSM)) will increase human…
- Trial name
- NCT01751100
- Testing
- HIV Test Offer, General Health Screen Offer
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- North Bronx Healthcare Network
HIV-1 Infection, Tuberculosis
PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB
This study was done to evaluate the effect of HIV and TB treatment on a commonly used birth control method. It enrolled women who were infected with HIV and TB and were taking efavirenz (EFV; Sustiva®; an anti-HIV medication)…
- Trial name
- PRIDE-HT (NCT02412436)
- Testing
- Depot medroxyprogesterone acetate
- Where
- 5 sites in Botswana, Kenya and 2 more
- Volunteers
- 62 people
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Early Childhood Development in HIV-Exposed Children
Evaluation of an Early Childhood Development Intervention for HIV-Exposed Children in Cameroon
There is substantial evidence that early childhood development (ECD) programming can improve child health and development outcomes.
- Trial name
- NCT03195036
- Testing
- Home-based ECD services
- Where
- Cameroon
- Volunteers
- 230 people
- Sponsor
- Duke University
HIV Infections
Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women
Prospective, open, single-arm trial of dolutegravir-tenofovir and emtricitabine or lamivudine (DTG-TDF-FTC or 3TC) in antiretroviral (ART) naïve HIV transgender women (TGW).
- Trial name
- TRANSViiV (NCT03033836)
- Testing
- ARV treatment
- Where
- Argentina
- Volunteers
- 60 people
- Sponsor
- Fundación Huésped
HIV/AIDS, Antiviral Toxicity
Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)
Increased comorbidities such as cardiovascular disease (CVD), are emerging problems in HIV infection but the mechanisms are unclear.
- Conditions
- HIV/AIDS, Antiviral Toxicity, Antiviral Drug Adverse Reaction, Mitochondrial Alteration
- Trial name
- UCLACAREMITO (NCT03251144)
- Testing
- Switch to E/C/FTC/TAF daily
- Where
- United States
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- University of California, Los Angeles
HIV Infections
A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study
Combination antiretroviral therapy for the treatment of HIV has a high pill burden. Two dual-tablets, abacavir-lamivudine and tenofovir-emtricitabine, are now licensed in the United States and will be available in Australia in…
- Trial name
- NCT00192634
- Testing
- Emtricitabine 200mg - Tenofovir 300mg, Abacavir 600mg - Lamivudine 300mg
- Where
- 31 sites in Australia
- Volunteers
- 357 people
- Sponsor
- Kirby Institute
HIV Infections
Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients
The lining of the gastrointestinal tract contains specialized lymphoid tissue that is part of the immune system. Like other parts of the immune system, HIV attacks this lymphoid tissue.
- Trial name
- NCT00069498
- Testing
- 5-aminosalicylic acid
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination
The purpose of this study is to see if adding 1 drug to an anti-HIV drug combination early in treatment against HIV can lower the viral load (amount of HIV in the blood) to a level so low that it cannot be measured…
- Trial name
- NCT00001132
- Testing
- Abacavir sulfate
- Where
- 30 sites in United States, Puerto Rico
- Volunteers
- 80 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
HIV/AIDS
Simplified Treatment of Anti-retrovirus in China (C-STAR)
To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.
- Trial name
- NCT03603977
- Testing
- Lpv/r+3TC
- Where
- China
- Volunteers
- 600 people
- Sponsor
- Guangzhou 8th People's Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.